FALAGARIO, UGO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 2.159
EU - Europa 1.940
AS - Asia 1.890
SA - Sud America 410
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 6.455
Nazione #
US - Stati Uniti d'America 2.077
SG - Singapore 1.001
IE - Irlanda 455
BR - Brasile 346
RU - Federazione Russa 323
CN - Cina 322
IT - Italia 294
SE - Svezia 285
HK - Hong Kong 268
DE - Germania 173
VN - Vietnam 127
GB - Regno Unito 72
FI - Finlandia 68
UA - Ucraina 67
FR - Francia 47
IN - India 46
CA - Canada 43
AT - Austria 36
CZ - Repubblica Ceca 23
MX - Messico 23
AR - Argentina 22
BD - Bangladesh 19
PL - Polonia 17
NL - Olanda 15
TR - Turchia 15
ZA - Sudafrica 15
IQ - Iraq 14
JP - Giappone 14
GR - Grecia 11
VE - Venezuela 11
ES - Italia 9
IR - Iran 8
BE - Belgio 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
CL - Cile 6
EG - Egitto 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
IL - Israele 5
KE - Kenya 5
PK - Pakistan 5
PY - Paraguay 5
AL - Albania 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
HU - Ungheria 3
KH - Cambogia 3
PS - Palestinian Territory 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MW - Malawi 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SD - Sudan 1
Totale 6.450
Città #
Dallas 500
Singapore 482
Dublin 453
Hong Kong 266
Chandler 240
Ashburn 199
Nyköping 184
Santa Clara 141
New York 135
Beijing 122
Munich 81
Los Angeles 50
Moscow 49
Helsinki 48
Princeton 42
São Paulo 41
Jacksonville 39
Rome 39
Ho Chi Minh City 38
London 26
Nuremberg 26
The Dalles 25
Hanoi 24
Pune 24
Bari 23
Milan 23
Dearborn 21
Turku 20
Düsseldorf 19
Wilmington 19
Frankfurt am Main 18
Vienna 16
Brooklyn 15
Falkenstein 14
Guangzhou 13
Olomouc 13
Seattle 13
Toronto 13
Assago 12
Belo Horizonte 12
Boardman 12
Nanjing 12
San Francisco 12
Council Bluffs 11
Des Moines 11
Shanghai 11
Brno 10
Montreal 10
Naples 10
Ottawa 10
Warsaw 10
Wuhan 10
Boston 9
Rio de Janeiro 9
Atlanta 8
Chicago 8
Da Nang 8
Genoa 8
Tokyo 8
Brussels 7
Haiphong 7
Johannesburg 7
Lauterbourg 7
Marousi 7
Pescara 7
Phoenix 7
Baghdad 6
Dhaka 6
Guarulhos 6
Jiaxing 6
Porto Alegre 6
Tehran 6
Chengdu 5
Chennai 5
Foggia 5
Manchester 5
San Jose 5
Stockholm 5
Ankara 4
Bishkek 4
Biên Hòa 4
Bologna 4
Buenos Aires 4
Buffalo 4
Campinas 4
Cape Town 4
Curitiba 4
Kyoto 4
Martina Franca 4
Massa Lombarda 4
Nairobi 4
Norwalk 4
Paris 4
Portsmouth 4
Quảng Ngãi 4
Redwood City 4
Ribeirão Preto 4
Shenyang 4
São José do Rio Preto 4
Thái Nguyên 4
Totale 3.928
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 204
Evaluation of citrate-based nutraceutical combinations and their impact on chemolysis in the management of urinary diversion device: a randomised double-blind placebo-controlled study on improved quality of life and clinical outcomes 166
Artificial intelligence and radiomics applications in adrenal lesions: a systematic review 160
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 139
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 121
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 116
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 116
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 112
Elderly patients and prostate biopsy. How old is too old? 110
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data 107
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 106
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 103
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 102
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 97
Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests 96
Advanced ureteroscopic techniques for the management of kidney stones 93
A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques 92
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 88
Male esthetic genital surgery: recommendations and gaps to be filled 88
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 84
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 83
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 82
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 80
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators 77
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 76
Elderly patients and prostate biopsy. How old is too old? 76
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 75
Prostate cancer biomarkers: a practical review based on different clinical scenarios 75
Sexual function recovery following open and robotic radical prostatectomy: results of an academic penile rehabilitation program 72
Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center 72
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  72
Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index 71
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 71
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 70
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 70
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 68
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 68
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 63
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 61
Techniques for Penile Augmentation Surgery: A Systematic Review of Surgical Outcomes, Complications, and Quality of Life 60
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 59
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 58
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease 58
Nomogram predicting 30-day mortality after nephrectomy in the contemporary era: Results from the SEER database 57
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 57
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 53
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy 53
Oncological outcomes of whole-gland cryoablation in patients with prostate cancer and high risk of lymph node invasion 51
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 50
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study 50
Stapled W-shaped (Hautmann) Orthotopic Ileal Neobladder. Functional Results and Complications over a 13-year Period 49
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” 49
Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extension according to nccn risk categories: implication for surgical planning 47
Mini invasive approaches in the treatment of small renal masses: TC-guided renal cryoablation in elderly 46
Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion 46
Minimally invasive surgical therapies (MISTs) for lower urinary tract symptoms (LUTS): promise or panacea? 46
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? 45
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 45
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization 44
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role 43
A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer 43
ZSI-375 artificial urinary sphincter: efficacy, safety, and long-term outcomes 43
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care 42
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression 42
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series 41
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and Association with Molecular Subtypes-Preliminary Report 41
Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies 41
Impact of low-intensity extracorporeal shockwave therapy on vascular parameters and sexual function in patients with arteriogenic erectile dysfunction 41
Penoscrotal approach for inflatable penile prosthesis implant: why it should be preferred 40
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy 40
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer 40
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences 39
Radiomics in prostate cancer: an up-to-date review 39
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy 39
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 38
An original surgical approach to manage complete rectal lumen obliteration following stapled hemorrhoidopexy 38
Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer 37
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted Biopsy 37
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 36
Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group 36
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy 35
The Role of miRNA in the Management of Localized and Advanced Renal Masses, a Narrative Review of the Literature 35
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification 35
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working Group 35
UroLift to preserve seminal parameters in young male with LUTS from BPH 34
A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection 34
Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer 33
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 33
Robotic-assisted surgery for the treatment of urologic cancers: recent advances 32
Decipher Score predicts prostate specific antigen persistence after prostatectomy 32
Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms 31
The impact the COVID-19 pandemic on urology literature: a bibliometric analysis 30
Is night-time surgical procedure for renal graft at higher risk than during the day? A single center study cohort of 179 patients 30
How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database 29
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level 29
Does race impact functional outcomes in patients undergoing robotic partial nephrectomy? 29
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs 29
Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Functional Outcomes in Males 28
Positive Surgical Margins After Anterior Robot-assisted Radical Prostatectomy: Assessing the Learning Curve in a Multi-institutional Collaboration 27
Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies 27
Totale 6.168
Categoria #
all - tutte 49.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 0 18 23 27 30 8 9
2021/2022319 13 13 10 11 33 7 26 11 56 62 6 71
2022/20231.211 116 86 37 62 72 97 8 98 534 34 41 26
2023/2024669 40 34 26 13 28 184 133 33 39 37 22 80
2024/20252.160 150 28 59 44 62 238 224 126 592 172 203 262
2025/20262.235 286 500 603 420 289 137 0 0 0 0 0 0
Totale 6.876